Accuray Incorporated (ARAY) Stock Price

ARAYStock

$0.16−91.15%52W

Market Cap$18.60M

P/E—

PEG Ratio29.49

Div yield—

Beta1.36

ARAY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-70.98%

Price vs S&P 500 (4W)-33.80%

PEG Ratio29.49

VGM Score38.96

P/CF (Annual)11.50x

Book Value / Share (Quarterly)$0.35

P/TBV (Annual)1.23x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-3.52%

Cash Flow / Share (Quarterly)$-0.11

Price vs S&P 500 (YTD)-92.94%

Gross Margin (TTM)27.71%

Net Profit Margin (TTM)-12.24%

EPS (TTM)$-0.41

10-Day Avg Trading Volume2.01M

EPS Excl Extra (TTM)$-0.41

Revenue Growth (5Y)0.28%

EPS (Annual)$-0.40

ROI (Annual)-25.95%

Gross Margin (Annual)27.73%

Net Profit Margin (5Y Avg)-3.88%

Cash / Share (Quarterly)$0.34

Revenue Growth QoQ (YoY)-20.87%

ROA (Last FY)-11.09%

Revenue Growth TTM (YoY)-12.34%

EBITD / Share (TTM)$-0.17

ROE (5Y Avg)-36.34%

Operating Margin (TTM)-7.18%

Cash Flow / Share (Annual)$-0.11

P/B Ratio0.45x

P/B Ratio (Quarterly)0.74x

Net Income / Employee (Annual)$-49,700

EV / Revenue (TTM)0.31x

Net Interest Coverage (TTM)-1.64x

ROA (TTM)-10.96%

EV / EBITDA (TTM)19.32x

EPS Incl Extra (Annual)$-0.40

Current Ratio (Annual)1.50x

Quick Ratio (Quarterly)0.68x

3-Month Avg Trading Volume5.69M

52-Week Price Return-91.15%

Revenue / Employee (TTM)$406,000

Tangible BV / Share (Quarterly)$0.21

P/S Ratio (Annual)0.05x

Asset Turnover (Annual)0.91x

52-Week High$1.86

Operating Margin (5Y Avg)-0.52%

EPS Excl Extra (Annual)$-0.40

CapEx CAGR (5Y)20.36%

Tangible BV CAGR (5Y)-18.33%

26-Week Price Return-61.08%

Quick Ratio (Annual)0.68x

13-Week Price Return-39.95%

Total Debt / Equity (Annual)3.55x

Current Ratio (Quarterly)1.50x

Enterprise Value$125.84M

Revenue / Share Growth (5Y)-5.32%

Asset Turnover (TTM)0.90x

Book Value / Share Growth (5Y)-14.36%

Revenue / Employee (Annual)$406,000

Inventory Turnover (Annual)2.02x

Pretax Margin (Annual)-11.75%

Cash / Share (Annual)$0.34

3-Month Return Std Dev125.88%

Gross Margin (5Y Avg)32.69%

Net Income / Employee (TTM)$-49,700

EBITDA CAGR (5Y)-5.05%

ROE (Last FY)-117.97%

Net Interest Coverage (Annual)-1.53x

EPS Basic Excl Extra (Annual)$-0.40

P/FCF (TTM)1.52x

Receivables Turnover (TTM)5.21x

EV / Free Cash Flow (TTM)9.50x

Total Debt / Equity (Quarterly)3.55x

EPS Incl Extra (TTM)$-0.41

Receivables Turnover (Annual)5.21x

ROI (TTM)-25.63%

P/S Ratio (TTM)0.05x

Pretax Margin (5Y Avg)-3.23%

Revenue / Share (Annual)$3.28

Tangible BV / Share (Annual)$0.21

Price vs S&P 500 (52W)-106.69%

Year-to-Date Return-81.01%

5-Day Price Return-28.68%

EPS Normalized (Annual)$-0.40

ROA (5Y Avg)-3.56%

Net Profit Margin (Annual)-12.24%

Month-to-Date Return-42.35%

Cash Flow / Share (TTM)$-0.02

EBITD / Share (Annual)$-0.17

Operating Margin (Annual)-7.18%

LT Debt / Equity (Annual)3.51x

P/CF (TTM)8.95x

ROI (5Y Avg)-8.03%

LT Debt / Equity (Quarterly)3.51x

EPS Basic Excl Extra (TTM)$-0.41

P/TBV (Quarterly)1.23x

P/B Ratio (Annual)0.74x

Inventory Turnover (TTM)2.02x

Pretax Margin (TTM)-11.75%

Book Value / Share (Annual)$0.35

Price vs S&P 500 (13W)-42.64%

Beta1.36x

P/FCF (Annual)6.50x

Revenue / Share (TTM)$3.18

ROE (TTM)-99.04%

52-Week Low$0.15

vGradeA

gGradeF

mGradeF

vgmGradeD

ARAY Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 19, 2026	—	$0.00	—
Q1 2026	May 6, 2026	-$0.05	-$0.07	-35.60%(-$0.02)
Q4 2025	Feb 4, 2026	-$0.11	-$0.11	+2.18%(+$0.00)
Q3 2025	Nov 5, 2025	-$0.05	-$0.14	-178.40%(-$0.09)
Q2 2025	Aug 13, 2025	$0.01	$0.01	-63.33%(-$0.01)

ARAY Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.29

2.17

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
ARAYAccuray Incorporated	A	F	F	0.0x	0.3%	27.7%	-7.2%	$0.16
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Accuray Incorporated

Accuray manufactures the CyberKnife, a precision radiation oncology system for treating cancers and tumors throughout the body. The system automatically detects and corrects for tumor and patient movement in real-time, delivering high-dose radiation with sub-millimeter accuracy while patients breathe normally and without requiring manual intervention. This technology sets the standard for precision radiation therapy in cancer treatment.

ARAY Next Earnings Report

Report dateNov 4, 2026

QuarterQ3 2026

Report timeAMC

Also reporting on Nov 4, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

BCHTBirchtech Corp.Measuring & Controlling Devices
MLSSMilestone Scientific, Inc. Common StockOrthopedic & Prosthetic Devices
ITOCiTonic Holdings Ltd Class A Ordinary SharesElectromedical Equipment
DAIOData I/O CorpInstruments for Measuring
LFWDLifeward Ltd. Ordinary SharesOrthopedic & Prosthetic Devices
CLIRClearSign Technologies Corporation Common Stock (DE)Industrial Instruments
BNGOBionano Genomics, Inc. Common StockLab Analytical Instruments
IRIXIridex CorpElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

2.2

Sell

Consensus rating

52-Week Range

Low$0.15

High$1.86